FTGS
First Trust Growth Strength ETF
NAV as of
4 Week: 23.62 - 24.53
52 Week: 19.90 - 24.59
Latest Closing Price
23.90
Premium / Discount
0.24
Expense Ratio
0.6%
Investment Objective
The investment seeks investment results that correspond generally to the price and yield (before the fund’s fees and expenses) of an equity index called The Growth Strength Index. Under normal market conditions, the fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the common stocks and real estate investment trusts (“REITs”) that comprise the index. The index seeks to provide exposure to a mix of domestic equities with filters for liquidity, return on equity, long-term debt, revenue and cash flow growth. It is non-diversified.
Main Fund Characteristics
Performance
Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
---|---|---|---|
YTD | 15.13 | 0.96 | 15.82 |
1 Day | -1.17 | 0.00 | 0.00 |
1 Week | -3.55 | 1.91 | -1.86 |
1 Month | -1.51 | 3.72 | -0.41 |
3 Months | 2.65 | 5.94 | 0.45 |
6 Months | 8.68 | 9.48 | 0.92 |
1 Year | 0.00 | 0.00 | 0.00 |
2 Years | 0.00 | 0.00 | 0.00 |
3 Years | 0.00 | 0.00 | 0.00 |
5 Years | 0.00 | 0.00 | 0.00 |
10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
Dividend Frequency
Lastest Dividend
Ex Date | Payment Date | Dividend Payout per unit |
---|---|---|
26/06/2023 | 29/06/2023 | 0.0329 |
23/03/2023 | 30/03/2023 | 0.0638 |
22/12/2022 | 29/12/2022 | 0.0428 |
Portfolio Data
Total Number of Holdings: 51
Number of Bond Holdings: 0
Number of Equity Holdings: 50
Total Market Value: 22,876,518
Portfolio Composition
Top 10 Holdings
% Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
---|---|---|---|---|---|
1 | Horizon Therapeutics PLC | 3.3379 | 620 | 310 | 70,097 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
Size | % of portfolio |
---|---|
Giant | 20.75 |
Large | 44.47 |
Medium | 34.72 |
Small | 0.00 |
Micro | 0.00 |
Equity Style Box Breakdown
0 | 0 | 0 | Large |
0 | 0 | 0 | Mid |
0 | 0 | 0 | Small |
Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
15.9474
Price/Book*
3.5513
Price/Sales*
1.6364
Price/Cash Flow*
9.2926
Dividend Yield*
1.7916
Growth Measures
Long-Term Earnings
17.3837
Historical Earnings
41.4284
Sales Growth
25.2637
Cash-Flow Growth
44.7761
Book-Value Growth
14.4101
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
Detail | Value |
---|---|
Average Effective Duration | 0 |
Average Effective Maturity (Years)* | 0 |
Average Credit Quality | 0 |
Average Weighted Coupon* | 0 |
Average Weighted Price* | 0 |
Bond Style Box Breakdown
0 | 0 | 0 | High | Quality |
0 | 0 | 0 | Med | |
0 | 0 | 0 | Low | |
Ltd | Mod | Ext | ||
Interest-Rate Sensitivity |
Credit Quality
Type | % Bonds |
---|---|
N.A |
Bond Sector
Bond Maturity
% Bonds | |
---|---|
N.A |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.